Cargando…
Exploring the Activity Profile of TbrPDEB1 and hPDE4 Inhibitors Using Free Energy Perturbation
[Image: see text] Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the parasite Trypanosoma brucei (T.b.). A validated target for the treatment of HAT is the parasitic T.b. cyclic nucleotide phosphodiesterase B1 (TbrPDEB1). Although nanomolar TbrPDEB1 inhibitors have bee...
Autores principales: | Zara, Lorena, Moraca, Francesca, Van Muijlwijk-Koezen, Jacqueline E., Zarzycka, Barbara, Abel, Robert, de Esch, Iwan J. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190044/ https://www.ncbi.nlm.nih.gov/pubmed/35707144 http://dx.doi.org/10.1021/acsmedchemlett.1c00690 |
Ejemplares similares
-
Gene Conversion Transfers the GAF-A Domain of Phosphodiesterase TbrPDEB1 to One Allele of TbrPDEB2 of Trypanosoma brucei
por: Kunz, Stefan, et al.
Publicado: (2009) -
Discovery of Diaryl Ether Substituted Tetrahydrophthalazinones as TbrPDEB1 Inhibitors Following Structure-Based Virtual Screening
por: de Heuvel, Erik, et al.
Publicado: (2021) -
Targeting a Subpocket
in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1)
Enables the Structure-Based Discovery
of Selective Inhibitors with Trypanocidal Activity
por: Blaazer, Antoni R., et al.
Publicado: (2018) -
Design, Synthesis, and
Structure–Activity Relationships
of Highly Potent 5-HT(3) Receptor Ligands
por: Verheij, Mark H. P., et al.
Publicado: (2012) -
Structure–Activity Relationships of Quinoxaline-Based 5-HT(3)A and 5-HT(3)AB Receptor-Selective Ligands
por: Thompson, Andrew J, et al.
Publicado: (2013)